Good question. Although it could be argued that the recent thrust has a lot to do with how undervalued PAR was post the successful trial.
If there wasn't more potential news on the horizon then I'd definitely be looking for significant consolidation / correction to kick in. But it may take a bit of courage to walk away with as much potential news due in Q1/Q2 2019 such as....
- Secondary end-point data (normally a bit ho hum - but in this case could provide strong evidence around the unique MOA of PPS given we will (hopefully) see the MRI results - a pure objective parameter that won't be subject to potential misinterpretation by the market)
- MPS SAS - bearing in mind there could be a business built just around this indication
- ex-NFL players - will raise news in the US - although I wonder how much interest there will be from American traders
And there is a lot more to come too. The filing of the IND in Q3 CY2019 would be worthwhile waiting for alone.
I'm pleased I didn't walk away mid-January - but am struggling to see why I'd walk away just yet - and particularly as there seems to best much potential upside around news
Lots more to come
- Forums
- ASX - By Stock
- PAR
- TA view- all time high daily close
TA view- all time high daily close, page-2
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
24.0¢ | 25.0¢ | 23.0¢ | $101.6K | 424.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 144266 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 18540 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 134266 | 0.230 |
5 | 128003 | 0.225 |
4 | 94545 | 0.220 |
2 | 60000 | 0.215 |
5 | 89516 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 18540 | 1 |
0.250 | 10000 | 1 |
0.260 | 26521 | 4 |
0.270 | 10000 | 1 |
0.275 | 16347 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
PAR (ASX) Chart |